Pre-Clinical CNS Pipeline

Kv3.1/3.2 Program

Small molecule Kv3.1 / Kv3.2 potassium ion channels activators for improving cognitive dysfunction and negative symptoms in schizophrenia and other illnesses such as Autism Spectrum Disorder and Alzheimer’s Disease

Pan Nav Program

Small molecule pan Nav (1.7/1.8/1.9) inhibitors for the potential treatment of chronic pain and other potentially large unmet medical needs

For any partnering enquiries, please contact us here